文献速递消化内镜消化道出血

伏诺拉生与质子泵抑制剂对胃ESD术后出血的多中心比较

Vonoprazan versus proton pump inhibitors for postendoscopic submucosal dissection bleeding in the stomach: a multicenter population-based comparative study.
PubMed 文献 · Gastrointest Endosc · 2021-07-06

基于2014-2018年9家医院的全国性回顾性队列,倾向性评分匹配627对患者,比较胃ESD术后伏诺拉生与PPI的出血率。伏诺拉生组总体出血率(11.9% vs 17.2%,P=.008)及术后第2-30天出血率(7.8% vs 11.8%,P=.015)显著低于PPI组。再入院率、输血及额外手术无显著差异,两组均无30天内死亡。

要点

  • 伏诺拉生组总体ESD术后出血率显著低于PPI组(11.9% vs 17.2%)
  • 第2-30天出血率伏诺拉生组亦显著更低(7.8% vs 11.8%)
  • 再入院、输血及延迟穿孔手术两组无显著差异

核心结论

  • 伏诺拉生较PPI降低胃ESD术后出血率,需前瞻性研究确认。

研究设计与样本

  • 2014-2018年9家医院全国性回顾性队列,倾向性评分匹配627对患者。

主要发现

  • 伏诺拉生组总体出血率11.9% vs PPI组17.2%,P=.008。
  • 第2-30天出血率7.8% vs 11.8%,P=.015。
  • 再入院率2.4% vs 4.1%,P=.081;输血2.1% vs 3.0%,P=.15;延迟穿孔手术.5% vs 1.0%,P=.32。
  • 两组30天内均无死亡。
  • Cox回归显示伏诺拉生使用、胃窦部位、阿司匹林、直接口服抗凝药、Charlson合并症指数≥2与30天内出血风险增加相关。

临床怎么用

  • 胃ESD术后可考虑使用伏诺拉生替代PPI以降低出血风险。

局限性

  • 回顾性设计,需前瞻性研究确认结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The effectiveness of vonoprazan relative to that of proton pump inhibitors (PPIs) after gastric endoscopic submucosal dissection (ESD) is unclear. Although previous studies used post-ESD ulcer healing as the outcome measure, post-ESD bleeding rate is the most objective and appropriate outcome measure because it has less ascertainment bias. We aimed to compare the post-ESD bleeding rates between vonoprazan and PPIs. METHODS: This nationwide population-based retrospective cohort study was conducted between 2014 and 2018 and involved 9 hospitals. After 2 days of intravenous PPI administration, either vonoprazan or PPI was administrated from postoperative day 2 to 30. RESULTS: Overall, data of 1715 patients (627 patient pairs) were analyzed through propensity score matching. The vonoprazan group had significantly lower post-ESD bleeding rates than the PPI group (overall, 11.9% vs 17.2%, P = .008; bleeding between days 2 and 30, 7.8% vs 11.8%, P = .015). The readmission rate because of post-ESD bleeding was lower in the vonoprazan group (2.4% vs 4.1%, P = .081). Blood transfusion (2.1% vs 3.0%, P = .15) and additional surgery because of delayed perforation (.5% vs 1.0%, P = .32) were not significantly different between the 2 groups. No deaths within 30 days occurred in both groups. On Cox regression analysis, vonoprazan use, lesion location (antrum), aspirin use, direct oral anticoagulant use, and Charlson Comorbidity Index (≥2) were associated with an increased risk of post-ESD bleeding within 30 days. CONCLUSIONS: Vonoprazan has a lower post-ESD bleeding rate than PPIs. Further prospective studies are required to confirm these results.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Shiratori Y, Niikura R, Ishii N, et al. Vonoprazan versus proton pump inhibitors for postendoscopic submucosal dissection bleeding in the stomach: a multicenter population-based comparative study. Gastrointest Endosc. 2021. PMID: 34237329. doi:10.1016/j.gie.2021.06.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。